Diamyd Medical AB (FRA:DMN) Change In Inventory : €0.00 Mil (TTM As of Feb. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB Change In Inventory?

Diamyd Medical AB's change in inventory for the quarter that ended in Feb. 2025 was €0.00 Mil. It means Diamyd Medical AB's inventory stayed the same from Nov. 2024 to Feb. 2025 .

Diamyd Medical AB's change in inventory for the fiscal year that ended in Aug. 2024 was €0.00 Mil. It means Diamyd Medical AB's inventory stayed the same from Aug. 2023 to Aug. 2024 .

Diamyd Medical AB's Total Inventories for the quarter that ended in Feb. 2025 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Diamyd Medical AB's Days Inventory for the quarter that ended in Feb. 2025 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diamyd Medical AB's Inventory-to-Revenue for the quarter that ended in Feb. 2025 was 0.00.

Diamyd Medical AB Change In Inventory Historical Data

The historical data trend for Diamyd Medical AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Change In Inventory Chart

Diamyd Medical AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Change In Inventory

Get a 7-Day Free Trial

Diamyd Medical AB Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Diamyd Medical AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Diamyd Medical AB (FRA:DMN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diamyd Medical AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.096	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diamyd Medical AB's Inventory Turnover for the quarter that ended in Feb. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.096	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diamyd Medical AB's Inventory to Revenue for the quarter that ended in Feb. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.008
	=	0.00

Diamyd Medical AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

DYMDF:USA DMYD B:Sweden

Address

Kungsgatan 29, Stockholm, SWE, SE-111 56

Website

https://www.diamyd.com

Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.